Document Detail


Clarification of trial end points presented in a recent review of linaclotide.
MedLine Citation:
PMID:  22149576     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Response to: Roque MV, Camilleri M. Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation. Expert Rev. Gastroenterol. Hepatol. 5(3), 301-310 (2011).
Authors:
Jeffrey M Johnston; Harvey A Schneier
Related Documents :
21834256 - Methods of sputum decontamination with emphasis on local tuberculosis laboratories.
17440376 - Body dysmorphic disorder: diagnosis and approach.
18090436 - Musculoskeletal disorders in referrals for suspected lumbosacral radiculopathy.
6480676 - Upper extremity involvement in trevor disease.
9489046 - The life-time rates of three major mood disorders and four major anxiety disorders in a...
18287946 - A model of behavioral treatments for self-mutilation behavior in lesch-nyhan syndrome.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of gastroenterology & hepatology     Volume:  6     ISSN:  1747-4132     ISO Abbreviation:  Expert Rev Gastroenterol Hepatol     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2011-12-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101278199     Medline TA:  Expert Rev Gastroenterol Hepatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  13-4     Citation Subset:  IM    
Affiliation:
Ironwood Pharmaceuticals, Inc., 301 Binney Street, Cambridge, MA 02142, USA. jjohnston@ironwoodpharma.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cumyl Ester as the C-Terminal Protecting Group in the Enantioselective Alkylation of Glycine Benzoph...
Next Document:  Crofelemer for the treatment of secretory diarrhea.